Skip to main content

Seminar Series 2022 – 2023

Fall 2022

  1. July 7, 2022 – Introduction and Program Review. Cindy Feltner and David Gerber.
  2. July 28, 2022 – “Intraoperative Redosing of Surgical Antibiotic Prophylaxis in Addition to Preoperative Prophylaxis Versus Single-dose Prophylaxis for the Prevention of Surgical Site Infection.” Ann Surg 2022; 275: 1050-1057. David Gerber.
  3. August 11, 2022 – “Obstructive sleep apnea and risk of motor vehicle accident.” Sleep Medicine 85 (2021): 196-203. Cindy Feltner.
  4. August 25, 2022 – . Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial. JAMA Cardiol. Published online June 15, 2022. Brian Jensen.
  5. September 8, 2022 – 3D Digital Tomosynthesis vs 2D Mammography for breast cancer screening. Pattacini P, Nitrosi A, Giorgi Rossi P, et al. A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone. Radiology. 2022;303(2):256-266. Sheryl Jordan.
  6. September 29, 2022 – New diabetic agents and chronic kidney disease. Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. NEJM. 2021; 384(2) 129-139. Stephen DeCherney.
  7. October 13, 2022 – Acute Ischemic Stroke; Kvistad CE, Næss H, Helleberg BH, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022;21(6):511-519. Michael Wang.
  8. October 27, 2022 – Physical Rehabilitation in the hospitalized Heart Failure Patient, REHAB-HF clinical trial (NEJM 2021). Paul Thananopavarn.
  9. November 10, 2022 – TBD.
  10. October 21, 2022 – A Systematic Review of the Methods of Diagnostic Accuracy Studies of the Afirma Gene Expression Classifier. Thyroid. 2017. Vol 27, No. 10, 1215-1222. Jen Jen Yeh.
  11. December 1, 2022 – Immune Checkpoint Inhibitors and head and neck cancers, Keynote 048. Siddhart Sheth.
  12. December 8, 2022 – Check-in and review with 1st year Scholars. Cindy Feltner and David Gerber.